• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

反义寡核苷酸对 PK-M 互斥可变剪接的调控。

Manipulation of PK-M mutually exclusive alternative splicing by antisense oligonucleotides.

机构信息

Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724 , USA; Watson School of Biological Sciences, Cold Spring Harbor, NY 11724, USA.

出版信息

Open Biol. 2012 Oct;2(10):120133. doi: 10.1098/rsob.120133.

DOI:10.1098/rsob.120133
PMID:23155487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3498831/
Abstract

Alternative splicing of the pyruvate kinase M gene involves a choice between mutually exclusive exons 9 and 10. Use of exon 10 to generate the M2 isoform is crucial for aerobic glycolysis (the Warburg effect) and tumour growth. We previously demonstrated that splicing enhancer elements that activate exon 10 are mainly found in exon 10 itself, and deleting or mutating these elements increases the inclusion of exon 9 in cancer cells. To systematically search for new enhancer elements in exon 10 and develop an effective pharmacological method to force a switch from PK-M2 to PK-M1, we carried out an antisense oligonucleotide (ASO) screen. We found potent ASOs that target a novel enhancer in exon 10 and strongly switch the splicing of endogenous PK-M transcripts to include exon 9. We further show that the ASO-mediated switch in alternative splicing leads to apoptosis in glioblastoma cell lines, and this is caused by the downregulation of PK-M2, and not by the upregulation of PK-M1. These data highlight the potential of ASO-mediated inhibition of PK-M2 splicing as therapy for cancer.

摘要

丙酮酸激酶 M 基因的可变剪接涉及到外显子 9 和 10 之间的相互排斥选择。使用外显子 10 生成 M2 同工酶对于有氧糖酵解(瓦堡效应)和肿瘤生长至关重要。我们之前的研究表明,激活外显子 10 的剪接增强子元件主要存在于外显子 10 本身,删除或突变这些元件会增加癌细胞中外显子 9 的包含。为了系统地在外显子 10 中寻找新的增强子元件,并开发一种有效的药理学方法迫使从 PK-M2 切换到 PK-M1,我们进行了反义寡核苷酸 (ASO) 筛选。我们发现了针对外显子 10 中新型增强子的有效 ASO,可强烈切换内源性 PK-M 转录物的剪接以包含外显子 9。我们进一步表明,ASO 介导的剪接方式改变导致神经胶质瘤细胞系发生细胞凋亡,这是由 PK-M2 的下调引起的,而不是由 PK-M1 的上调引起的。这些数据强调了 ASO 介导的 PK-M2 剪接抑制作为癌症治疗的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec66/3498831/a3f291fecad6/rsob-2-120133-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec66/3498831/9b24277afb5e/rsob-2-120133-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec66/3498831/7e6dfb991acf/rsob-2-120133-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec66/3498831/a4a5c5409c44/rsob-2-120133-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec66/3498831/a3f291fecad6/rsob-2-120133-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec66/3498831/9b24277afb5e/rsob-2-120133-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec66/3498831/7e6dfb991acf/rsob-2-120133-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec66/3498831/a4a5c5409c44/rsob-2-120133-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec66/3498831/a3f291fecad6/rsob-2-120133-g4.jpg

相似文献

1
Manipulation of PK-M mutually exclusive alternative splicing by antisense oligonucleotides.反义寡核苷酸对 PK-M 互斥可变剪接的调控。
Open Biol. 2012 Oct;2(10):120133. doi: 10.1098/rsob.120133.
2
Exon-centric regulation of pyruvate kinase M alternative splicing via mutually exclusive exons.通过互斥外显子调控丙酮酸激酶 M 可变剪接的外显子中心调控。
J Mol Cell Biol. 2012 Apr;4(2):79-87. doi: 10.1093/jmcb/mjr030. Epub 2011 Nov 1.
3
The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism.hnRNP A1/A2 和 PTB 等可变剪接抑制剂影响丙酮酸激酶同工酶的表达和细胞代谢。
Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):1894-9. doi: 10.1073/pnas.0914845107. Epub 2010 Jan 19.
4
Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival.细胞毒性药物治疗后WT1基因表达和外显子5剪接的破坏:外显子5的反义下调改变靶基因表达并抑制细胞存活。
Mol Cancer Ther. 2004 Nov;3(11):1467-84.
5
ASO-Based PKM Splice-Switching Therapy Inhibits Hepatocellular Carcinoma Growth.基于 ASO 的 PKM 剪接转换治疗抑制肝癌生长。
Cancer Res. 2022 Mar 1;82(5):900-915. doi: 10.1158/0008-5472.CAN-20-0948.
6
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer.c-Myc 调控的 HnRNP 蛋白使肿瘤中的丙酮酸激酶 mRNA 剪接发生紊乱。
Nature. 2010 Jan 21;463(7279):364-8. doi: 10.1038/nature08697. Epub 2009 Dec 13.
7
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth.丙酮酸激酶的M2剪接异构体对癌症代谢和肿瘤生长很重要。
Nature. 2008 Mar 13;452(7184):230-3. doi: 10.1038/nature06734.
8
Multiple competing RNA structures dynamically control alternative splicing in the human ATE1 gene.多种竞争性 RNA 结构动态控制人类 ATE1 基因的可变剪接。
Nucleic Acids Res. 2021 Jan 11;49(1):479-490. doi: 10.1093/nar/gkaa1208.
9
Alternative splicing of the pyruvate kinase M gene in a minigene system.丙酮酸激酶M基因在小基因系统中的可变剪接
Eur J Biochem. 1996 Jan 15;235(1-2):366-71. doi: 10.1111/j.1432-1033.1996.00366.x.
10
Repair of aberrant splicing in growth hormone receptor by antisense oligonucleotides targeting the splice sites of a pseudoexon.通过针对假外显子剪接位点的反义寡核苷酸修复生长激素受体的异常剪接。
J Clin Endocrinol Metab. 2010 Jul;95(7):3542-6. doi: 10.1210/jc.2009-1968. Epub 2010 Apr 28.

引用本文的文献

1
RNA-coupled CRISPR Screens Reveal ZNF207 as a Regulator of LMNA Aberrant Splicing in Progeria.RNA偶联的CRISPR筛选揭示ZNF207是早衰症中LMNA异常剪接的调节因子。
bioRxiv. 2025 Apr 26:2025.04.25.648738. doi: 10.1101/2025.04.25.648738.
2
Pyruvate Kinase M1/2 Proteoformics for Accurate Insights into Energy Metabolism Abnormity to Promote the Overall Management of Ovarian Cancer Towards Predictive, Preventive, and Personalized Medicine Approaches.丙酮酸激酶M1/2蛋白质组学,用于准确洞察能量代谢异常,以促进卵巢癌的整体管理,迈向预测性、预防性和个性化医学方法。
Metabolites. 2025 Mar 16;15(3):203. doi: 10.3390/metabo15030203.
3

本文引用的文献

1
Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis.通过短暂抑制亨廷顿合成实现亨廷顿病的持续治疗逆转。
Neuron. 2012 Jun 21;74(6):1031-44. doi: 10.1016/j.neuron.2012.05.009.
2
Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression.丙酮酸激酶 M2 特异性 siRNA 诱导细胞凋亡和肿瘤消退。
J Exp Med. 2012 Feb 13;209(2):217-24. doi: 10.1084/jem.20111487. Epub 2012 Jan 23.
3
Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation.核 PKM2 在 EGFR 激活时调节β-连环蛋白的转录激活。
PKM splice-switching ASOs induce upregulation of dual-specificity phosphatases and dephosphorylation of ERK1/2 in hepatocellular carcinoma.
PKM剪接转换反义寡核苷酸可诱导肝细胞癌中双特异性磷酸酶上调及ERK1/2去磷酸化。
J Biol Chem. 2025 Apr;301(4):108345. doi: 10.1016/j.jbc.2025.108345. Epub 2025 Feb 22.
4
Antisense oligonucleotide-mediated TRA2β poison exon inclusion induces the expression of a lncRNA with anti-tumor effects.反义寡核苷酸介导的TRA2β毒性外显子包含诱导具有抗肿瘤作用的长链非编码RNA的表达。
Nat Commun. 2025 Feb 15;16(1):1670. doi: 10.1038/s41467-025-56913-8.
5
Alternative splicing of modulatory immune receptors in T lymphocytes: a newly identified and targetable mechanism for anticancer immunotherapy.T淋巴细胞中调节性免疫受体的可变剪接:一种新发现的且可靶向的抗癌免疫治疗机制。
Front Immunol. 2025 Jan 7;15:1490035. doi: 10.3389/fimmu.2024.1490035. eCollection 2024.
6
Thermodynamic control of mismatch discrimination for extensive splicing regulation of PKM pre-mRNA.PKM前体mRNA广泛剪接调控中错配识别的热力学控制
RNA. 2025 Mar 18;31(4):475-485. doi: 10.1261/rna.080212.124.
7
Targeting SNRNP200-induced splicing dysregulation offers an immunotherapy opportunity for glycolytic triple-negative breast cancer.靶向 SNRNP200 诱导的剪接失调为糖酵解型三阴性乳腺癌提供了免疫治疗机会。
Cell Discov. 2024 Sep 17;10(1):96. doi: 10.1038/s41421-024-00715-7.
8
The roles and mechanisms of coding and noncoding RNA variations in cancer.编码和非编码RNA变异在癌症中的作用及机制
Exp Mol Med. 2024 Sep;56(9):1909-1920. doi: 10.1038/s12276-024-01307-x. Epub 2024 Sep 2.
9
A CRISPR-dCas13 RNA-editing tool to study alternative splicing.一种用于研究可变剪接的 CRISPR-dCas13 RNA 编辑工具。
Nucleic Acids Res. 2024 Oct 28;52(19):11926-11939. doi: 10.1093/nar/gkae682.
10
RNA structure in alternative splicing regulation: from mechanism to therapy.可变剪接调控中的RNA结构:从机制到治疗
Acta Biochim Biophys Sin (Shanghai). 2024 Jul 22;57(1):3-21. doi: 10.3724/abbs.2024119.
Nature. 2011 Dec 1;480(7375):118-22. doi: 10.1038/nature10598.
4
Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses.活性氧抑制丙酮酸激酶 M2 有助于细胞抗氧化反应。
Science. 2011 Dec 2;334(6060):1278-83. doi: 10.1126/science.1211485. Epub 2011 Nov 3.
5
Exon-centric regulation of pyruvate kinase M alternative splicing via mutually exclusive exons.通过互斥外显子调控丙酮酸激酶 M 可变剪接的外显子中心调控。
J Mol Cell Biol. 2012 Apr;4(2):79-87. doi: 10.1093/jmcb/mjr030. Epub 2011 Nov 1.
6
Targeting RNA to treat neuromuscular disease.靶向 RNA 治疗神经肌肉疾病。
Nat Rev Drug Discov. 2011 Aug 1;10(8):621-37. doi: 10.1038/nrd3459.
7
No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis.没有证据表明在肿瘤发生过程中丙酮酸激酶PKM1向PKM2的表达发生转变。
Oncotarget. 2011 May;2(5):393-400. doi: 10.18632/oncotarget.278.
8
Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth.乙酰化通过伴侣介导的自噬靶向丙酮酸激酶 M2 同工酶进行降解,并促进肿瘤生长。
Mol Cell. 2011 Jun 24;42(6):719-30. doi: 10.1016/j.molcel.2011.04.025.
9
Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1.丙酮酸激酶 M2 是一种受 PHF3 刺激的缺氧诱导因子 1 共激活剂。
Cell. 2011 May 27;145(5):732-44. doi: 10.1016/j.cell.2011.03.054.
10
Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy.反义寡核苷酸递送至小鼠中枢神经系统可改善严重脊髓性肌肉萎缩症的症状。
Sci Transl Med. 2011 Mar 2;3(72):72ra18. doi: 10.1126/scitranslmed.3001777.